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ABSTRACT
Objective: To determine the clinical presentations, of gastric stromal tumors with diagnostic methods, patholog
outcome after surgery.
Y and
Study Design: A case series.
Duration and Setting: From January 1988 to December 2002 at The Aga Khan University Hospital, Karachi.
Patients and Methods: All patients of age 14 years and above, diagnosed histopathologically to have gastric stro
tumors were included. The data of these patients was collected retrospectively from January 1988 to December 19 98 mat
prospectively from January 1999 to December 2002. All the patients were studied as a single group.
'and
Results: There were 11 patients. Their mean age was 54 years, with 8 males and 3 females. Five patients presented With
upper gastrointestinal bleeding, and 4 with lower gastrointestinal bl.eeding. Eight patients had pain ·,n epigastrium and
2
had vomrtrng. Upper gastrorntestmal endoscopy was done rn all patrents, and ultrasound was done rn 4 patients. CT scan
was done in 7 patients. Pre-operative diagnosis could be made in 6 patients. Only one patient had liver metastasis. Wedge
resection was performed in 5 proximal gastrectomy with gastroesophageal anastomosis in 3, and partial gastrectomy with
gastrojejunostomy in another 3 patients. The mean tumor size was 8.0 centimeters. Two patients had benign, 2 had
intermediate and 7 had malignant tumors. The mean duration of follow-up was 41 months. Follow-up was completed in
8 patients, out of whom 6 were alive, arid 2 patients expired due to other causes at the time of completion of this study.
Conclusion: Gastric stromal tumors are uncommon. Larger gastric stromal tumors are usually symptomatic with
gastrointestinal bleeding as a common presentation. Immunohistochemical techniques are required for the diagnosis.
Complete surgical resection is the curative therapy.
Gastric stromal fumors.
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Most of the gastric stromal tumors are asymptomatic, but
slowly growing tumors may present as symptomatic masses.a
Gastric stromal tumors are uncommon) Many of such tumors
may not originate from smooth muscles', therefore, these
tumors may be classified as GIST i.e. Gastrointestinal stromal
tumors and in relation to the stomach as gastric stromal
tumors.3
These tumors were classified depending on the type of tissue
from which they arisef that is smooth musclesf nervous tissue
or both of them.• With the advent of the electron microscopy
and inununohistochemical techniques these tumors are now
classified as benign, intermediate and malignant, depending
upon the tumor size and mitotic count.4 Immunohlstochemical techniques analyse the positivity of vimentin,
desmin, anti smooth muscle antibodies and S-100 to
differentiate between different tumors.s Although prediction
of the biological behaviour of these tumors is often difficult,
but in general malignant stromal tumors are mitotically more
active, more cellular, larger in size, and having adjacent organ
invasion.' The majority of gastric stromal tumors are grossly
well circumscribed, even those that prove to be malignant?
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Despite advances in technology, the pre-operative diagnosis
of gastric stromal tumors is often difficult. Helpful
investigations include: upper gastrointestinal endoscopy,
ultrasonography, CT scan and endoscopic ultrasound' As
gastric stromal tumors are usually radioresistant and
insensitive to chemotherapeutic agentsf the only curative
therapy is adequate surgical excision.6 Metastatic disease is
most common in liver and peritoneum.? Metastasis to local
lymph nodes does not occur, thus there does not appear to
be a need for lymph node dissection.!'
The objectives of the study were to determine the cliniCill
presentations, diagnostic methods and outcome after surgery of
these rare tumors at The Aga Khan University Hospital, Karachi.

pATIENTS AND METI-IOOS
It was a case series with combined retrospective and
prospective review conducted at The Aga Khan University
Hospital, Karachi from January 1988 to December 2002. The
data was collected retrospectively from 1988 to !998, and
. IS
prospectively from 1999 to December 2002. All adult pat,en
of age 14 years and above, diagnosed by histopathology, to
have gastric stromal tumors were included in the studY.
Patients less than 14 years of age, and patients with
incomplete medical record were excluded.
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. , deJ1l0 graphic data, presentations, diagnostic methods
.
and the type of surgical procedure performed were
All the slides were reviewed by the pathologist. The
were classified according to the new classification
benign, intermediate and malignant. The reasons for
:.:.lrc<teJI'""
i:Arrussron after the discharge from the hospital, and follow
"~"""'o'~patients were also reviewed. There were 4 patients
studied prospectively. Since all their features were
the retrospective group, therefore, all patients were
as a single group. TGM (Tumor, Grade, Metastasis)
was used to stage the disease.

were 11 patients. The mean age was 54 years. There
::1<1''"""'. and 3 female patients. Ischemic heart disease was
?.J,~rr11orb 1:dity in 4 patients, hypertension in 3, liver cirrhosis

;11\ilrheumatoJa arthritis in 1, smoking in 2, and goiter in 1
clinical features and the duration of these features
in Table I.

5

32

The size of the tumor ranged from 3.5cm to·21cm, with a mean
diameter of 8.0cm.The slides of all these patients were
reviewed by the histopafuologist, and these tumors were
reclassified according to a new classification system of Amin
et al. Two patients had benign tumors, 2 had intermediate,
and 7 patients had malignant tumors. One patient had stage I
disease, 3 patients had stage II, 3 patients had stage III, one
patient had stage IV A, and 3 patients had stage IV B disease.
Injury to splenic vessels occurred in one patient, during
surgery, leading to hemorrhage and splenectomy was done.
He was shifted to ICU, where he developed pneumonia and
ARDS, leading to death. One patient developed urinary tract
infection postoperatively, and he was treated with antibiotics.
The mean hospital stay was 11 days.
Four patients were re-admitted with pain epigastrium due to
acid peptic disease, 2 patients with upper gastrointestinal
bleeding, one patient with ischemic heart disease and one
patient with hepatic coma. One patient who had liver
metastasis was admitted for chemotherapy.
The mean duration of follow up was 41 months. Two patients
were lost to follow up, one of them was the patient with liver
metastasis, and he lost to follow up after 20 months of his
surgery, and another was lost to follow up 4 months after the
surgery. Among the remaining 8 patients, 6 patients were alive
at the time of completion of this study. One patient expired 8
years after surgery due to ischemic heart disease, and another
patient expired 3 years and 9 months after the surgery, due to
liver cirrhosis.
The stage of the disease, operative procedure and duration of
survival is shown in Table II.
Table II Stage of disease, operative procedure and survival.
S.No. Stage of
disease

· · hemoglobin was less than 10 gm/ dl in 3 patients, and 8
lfpatienrtshad hemoglobin of more than 10gm/ ell at the time of
•jmissi011. The liver function tests were normal in all the
rnmen'ts. Upper gastrointestinal endoscopy was used as a
iilgrJostic modality in all of these patients. The yield of the
gastrointestinal endoscopy was small and only
could be diagnosed to have gastric stromal tumors,
d''' .enrdo:3co·pic biopsy. The endoscopy showed ulcer in
patients, nodular lesions in 2, gastritis in 3,

If

~ bi~~:~~~;:'!~~~in l, and gastric outlet obstruction in 1 patient.
~

of abdomen was done in 4 patients. It
~owed a mass anterior to the pancreas in one patient.
The pre-operative C.T scan was done in 7 patients. ln 6
patients, it revealed a mass in stomach. In one patienC it
a mass inferior to the antral part of the stomach. No
metastasis or ascites was detected pre-operatively in
lhese patients.

With the help of these diagnostic modalities, the pre-operative
Provisional diagnosis of a gastric stromal tumor was made in
6patients. Wedge resection with negative tumor margin was
!'erfonned in 5 patients. In 3 patients, proximal gastrectomy
·
gastroesophageal anastomosis was performed. A partial
gastrectomy and gastrojejunostomy was performed in
3yatients because the tumor was in the pylorus of the
;lornach. One patient was found to have liver metastasis and
· Patients had tumor rupture, detected per-operatively.
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Operative
procedure
Wedge resection
Wedge resection
Wedge resection
Prox. gastrectomy with
gastroesophag.
anastomosis
Wedge resection
Partial gastrectomy and
gastrojejunal anastomosis
Proximal gastrectomy with

Swvival in
months
45 (ex~ired)
66
04 (lost to fo!low-u~!

96 (ex~ired l
54
26
20

gastroeso~hag.anastomosis

8

1VB

9

1VB

10

IVB

Partial gastrectomy with gastro
jejunal anastomosis
Proximal gastrectomy with
gastroesoehag.anastomosis
Partial gastrectomy and
gastrojejunal anastomosis

(lost to follow-up
after 20 months)

3S
49
21

DrscussroN
Tumors of smooth muscle origin account for 0.3% of gastric
lesions.n Many of such tumors may not originate from
smooth muscles2, and therefore, these tumors are called
gastric stromal tumors. A significant number of patients
have their tumors discovered during operation when they
present with bleeding, perforation, or obstruction.? The
surgeon is required to formulate adequate therapy usually in
an acute condition for a rare disease. Most of these tumors are
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asymptomatic.
Symptomatic
tumors
have
varied
presentations. Gastfo-intestinaJ bleeding was the common
presentation in this study, occurring in 9 patients. This was
followed by pain in epigastrium, vomiting, dysphagia and
anorexia. The incidence of gastrointestinal bleeding as
reported in the literature is up to 70%.12 However, these are
usually nonspecific and depend upon the size and location of
lesion.13
As pre-operative diagnosis of these tumors is often difficult, in
the literature pre-operative diagnosis could be made in
upto 15% of the cases.12 In our series the pre-operative
provisional diagnosis of gastric stromal tumors was made in 6
patients. Endoluminal ultrasonography has sensitivity of 80%
to 100% in detecting gastric stromal tumors and it also
differentiates benign from the malignant stromal tumors, as
decribed in the literature.9 A demarcated hypoechoic mass
that is contiguous with the muscularis propria layer of the
stomach is characteristic of a stromal tumor.9 Fine needle
aspiration and core biopsy are also described as pre operative
diagnostic methods.l4 These modalities were not used in our
patients.
Surgical resection of localized gastric stromal tumors is the
preferred treatment modality. Historically a 1 to 2 em margin
was thought to be necessary for adequate resection. Recently it
is demonstrated that the surgical goal should be complete
resection with negative resection margins, without
lymphadenectomy.14 In some cases, tumor size and location
may require extensive surgery, including partial or total
gastrectomy. Removal of all the gross disease improves the
outcome even in patients with advanced disease. The regional
lymphadenectomy would not result in beneficial effects''
because majority of these patients present with systemic
metastasis.'' In the present series, removal of all the gross
disease was done in 10 patients and one patient had liver
metastasis. Tumor rupture is said to have an adverse influence
on the survival of the patients.' In this study, 3 patients had
tumor rupture, because the tumor had already ulcerated prior
to surgery.
Currently a laparoscopic resection of gastric stromal tumors is
performed in some centres. A study done by Novitsky eta/.
showed a laparoscopic approach to surgical resection of
gastric stromal tumors was associated with low morbidity and
short hospital stay.'' The long-term follow-up (mean 36
months) in this study showed a disease-free survival of 92%.
The mean diameter of the gastric stromal tumors as described
in the literature is upto 7.3 centimeters. In this study, the mean
diameter is 8.0 centimeters. This seems that patients presented
in the advanced stage of the disease. The mean follow-up was
41 months, which is better than the study of Ludwig.!' The
local recurrence has been reported upto 10% to 12% in the
literature, but in our study no patient had local recurrence.
The rates of curative resection for gastric stromal tumors
ranges from 68% to 90%, and 5 years survival ranges from 32%
to 63%.14
A case reported by Shiwani showed 4 years postsurgery
follow-up in a patient operated for gastric stromal tumor,
without chemo-radiotherapy that did not show any evidence
qf disease.l7 In this study one patient expired 8 years after the
surgery due to ischemic heart disease, but having no evidence
of the tumor recurrence.
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The role of radiotherapy has yet to be dete .
~
there is no data available to support the ::•d. Pre5c1\l . ~
radiotherapy to these patients. Currentlv it . ll1tstration ~, '#
,, ls desc .b ~
C-kit receptor tyrosine k inase is expressed i
" ed lha If!
The tyrosine kinase inhibitor Glivac is the n/hese tu~ '.· ~o
1
designed molecular targeted drug therapy for !rst _ration,~ '[fJ
tumors)S Glivac is indicated in patients Wit~astnc stro~t~~ ~~
tumors or with metastatic disease.19 In one unresec!ab~ '~11
surgical resection, Glivac caused stabilization 0 study, Mt~
.
.
r regre .
the tumor m 84% of pahents. 20 True efficacy is unkno ss,onn~
the results of the ongoing prospective trials. Gliv Wn llntij
given to patients in this study.
ac Was not

0

CoNCLUSION
Gastric stromal tumors are uncommon. Larger tu
usually symptomatic. Immunohistochemical technimors are
required for the diagnosis. Complete surgical rese qtues '"
.
.
c~a
lead to prolongatwn of bfe, and may be a potential c "
patients with gastric stromal tumors.
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